James R. Kasinger - Net Worth and Insider Trading
James R. Kasinger Net Worth
The estimated net worth of James R. Kasinger is at least $3 Million dollars as of 2024-12-01. James R. Kasinger is the General Counsel and Secretary of CRISPR Therapeutics AG and owns about 62,597 shares of CRISPR Therapeutics AG (CRSP) stock worth over $3 Million. Details can be seen in James R. Kasinger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James R. Kasinger has not made any transactions after 2024-10-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James R. Kasinger
James R. Kasinger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James R. Kasinger owns 1 companies in total, including CRISPR Therapeutics AG (CRSP) .
Click here to see the complete history of James R. Kasinger’s form 4 insider trades.
Insider Ownership Summary of James R. Kasinger
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2024-10-14 | General Counsel and Secretary |
James R. Kasinger Latest Holdings Summary
James R. Kasinger currently owns a total of 1 stock. James R. Kasinger owns 62,597 shares of CRISPR Therapeutics AG (CRSP) as of October 14, 2024, with a value of $3 Million.
Latest Holdings of James R. Kasinger
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2024-10-14 | 62,597 | 51.17 | 3,203,088 |
Holding Weightings of James R. Kasinger
James R. Kasinger Form 4 Trading Tracker
According to the SEC Form 4 filings, James R. Kasinger has made a total of 4 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in CRISPR Therapeutics AG is the sale of 1,089 shares on October 14, 2024, which brought James R. Kasinger around $50,399.
Insider Trading History of James R. Kasinger
- 1
James R. Kasinger Trading Performance
James R. Kasinger Ownership Network
James R. Kasinger Owned Company Details
What does CRISPR Therapeutics AG do?
Who are the key executives at CRISPR Therapeutics AG?
James R. Kasinger is the General Counsel and Secretary of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include Chief Business Officer Samarth Kulkarni , Chief Financial Officer Raju Prasad , and Chief Medical Officer Phuong Khanh Morrow .
CRISPR Therapeutics AG (CRSP) Insider Trades Summary
Over the past 18 months, James R. Kasinger made 3 insider transaction in CRISPR Therapeutics AG (CRSP) with a net sale of 6,949. Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 184,630 shares made by Samarth Kulkarni , a net sale of 3,524 shares made by Raju Prasad , and a net sale of 3,366 shares made by .
In summary, during the past 3 months, insiders sold 35,382 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 35,382 shares. During the past 18 months, 198,469 shares of CRISPR Therapeutics AG (CRSP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 198,469 shares.
CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.
CRISPR Therapeutics AG Insider Transactions
James R. Kasinger Mailing Address
Above is the net worth, insider trading, and ownership report for James R. Kasinger. You might contact James R. Kasinger via mailing address: C/o Crispr Therapeutics, Inc., 610 Main Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
